ライフサイエンスコーパス: disease entity

1 -cell lymphoma has been established as a new disease entity.

2 e diagnosis and study of this underdiagnosed disease entity.

3 of ET and PMF do not represent a homogenous disease entity.

4 de additional evidence that each is a unique disease entity.

5 filling the diagnostic criteria for a single disease entity.

6 no reports of its use in patients with this disease entity.

7 s familial disorder may be a new or distinct disease entity.

8 d show the role of de novo mutations in this disease entity.

9 an drive new therapeutic strategies for this disease entity.

10 of MAC and the clinical implications of this disease entity.

11 tion in one of the genes associated with the disease entity.

12 ated essential thrombocythemia is a distinct disease entity.

13 to other complications suggesting a distinct disease entity.

14 s for follow-up of patients with this unique disease entity.

15 mphoma remains an incompletely characterized disease entity.

16 al endothelial disorder, or a completely new disease entity.

17 hes, outcome, and prognostic factors of this disease entity.

18 and could therefore be regarded as a single disease entity.

19 nd genotypic features characteristic of each disease entity.

20 ests that Kleine-Levin syndrome is a genuine disease entity.

21 asting doubt on its acceptance as a distinct disease entity.

22 lassified by itself or considered a distinct disease entity.

23 h, are managed clinically as if they are one disease entity.

24 ly ill patients not fitting into established disease entities.

25 mor subtypes represent biologically distinct disease entities.

26 and endometrioid) likely represent distinct disease entities.

27 ly led to their classification into separate disease entities.

28 nize subtypes of low grade B-NHL as separate disease entities.

29 clinically and immunophenotypically distinct disease entities.

30 rally considered to be separate and distinct disease entities.

31 disease continuum but do represent separate disease entities.

32 ft ventricular filling pressures in specific disease entities.

33 e biological underpinnings of these multiple disease entities.

34 opular since the late 18th century, to proto-disease entities.

35 associations might help classifying involved disease entities.

36 BCL, suggesting that they represent distinct disease entities.

37 iatric EoE and adult EoE represent different disease entities.

38 pitope specificity was not linked to certain disease entities.

39 ffective treatment for a number of difficult disease entities.

40 yndromes and sheds light on newly recognized disease entities.

41 MDS leading to improved distinction of these disease entities.

42 ity, motivating alternative biomarker-driven disease entities.

43 e common between neurodegeneration and other disease entities.

44 nable new strategies for treatment of select disease entities.

45 ting the notion that they represent distinct disease entities.

46 molecularly characterized 31 separate muscle disease entities.

47 s and incidence rates of over 120 recognized disease entities.

48 stology could indicate biologically distinct disease entities.

49 ar abnormalities that distinguish biological disease entities; (2) mutations, typically arising in su

50 Free-living amoebae cause three well-defined disease entities: a rapidly fatal primary meningoencepha

51 cohorts of patients diagnosed with a single disease entity, acute myeloid leukemia in first complete

52 genetic evidence for differentiating the two disease entities (AMAN and AIDP) and focuses our attenti

53 multiple geographic settings, ethnic groups, disease entities and caregiver types, to more fully eval

54 simulate the performance of XPCI on various disease entities and compare proposed XPCI systems in an

55 38% cited efforts to expand beyond approved disease entities and dosing strategies, respectively.

56 tic strategies that account for the discrete disease entities and their plasticity.

57 there is debate about whether it is a single disease entity and what role ANCA plays in its pathogene

58 that alter the response to therapy for some disease entities, and more will follow as pharmacogeneti

59 hat have been made about mental disorders as disease entities; and examine the evidence that mental d

60 -the art use of CT and US in diagnosing this disease entity; and to address the role of medical imagi

61 tor and sensory function are identified, new disease entities are being described and novel therapeut

62 lastic lymphoma associated with MCD is a new disease entity associated with HHV-8 infection.

63 These needs cross disease entities but some are disease specific.

64 thermore, idiosyncratic DILI is not a single disease entity but rather a spectrum of rare diseases wi

65 , suggesting that CIDP may not be a discrete disease entity but rather a spectrum of related conditio

66 atory myositis in children includes multiple disease entities, but is primarily made up of juvenile d

67 , cirrhosis has been seen to be not a single disease entity, but one that can be subclassified into d

68 hy, the final impression should identify the disease entity by name to assist the referring physician

69 itral flow velocity curves obtained from one disease entity can be valid in other disease states.

70 Here, we explored the presence of distinct disease entities characterized by specific pathophysiolo

71 and DLB may in fact represent 1 overlapping disease entity, characterized by the presence of mixed n

72 AK2 haplotype, designated 46/1, in all three disease entities compared to healthy controls (polycythe

73 the International Lymphoma Study Group, the disease entities currently recognized in the literature

74 Although commonly thought of as 2 separate disease entities, CVD and cancer possess various similar

75 that chronic ITP in childhood is a separate disease entity, dissimilar in many aspects to the newly

76 ptic abscesses have been recognized as a new disease entity, especially in adults.

77 tion, accurate and precise classification of disease entities facilitates the discovery of the molecu

78 Therefore, we propose a new disease entity-familial encephalopathy with neuroserpin

79 s esophagus remains a particularly important disease entity for which we should maintain up-to-date g

80 We have gathered annotations for disease entities from two curators, analyzed their disag

81 CXCL9, and CXCL10, which distinguished this disease entity from idiopathic pulmonary fibrosis and an

82 lescintigraphy can clearly differentiate one disease entity from the other.

83 man and help to define the concept for a new disease entity hallmarked by idiopathic generalized seiz

84 Several disease entities have been shown to predispose to hepato

85 ng five pathogenic types, each with specific disease entities: immune-complex GN, pauci-immune GN, an

86 to generate an annotated dataset that links disease entities in text to disease entries in a databas

87 rors are caused by the absence of associated disease entities in the abstract.

88 there are a limited number of structures and disease entities in the temporal bone with which one mus

89 of positive reactions and confirmed ACD as a disease entity in children.

90 CRS has been regarded as a single disease entity in clinical and genetic studies in the pa

91 ive mutations in FAT1 cause a distinct renal disease entity in four families with a combination of SR

92 lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification.

93 Disease entities included were tetralogy of Fallot (TOF)

94 l approaches to diagnose and treat different disease entities including those related to the over-nut

95 v(3)/t(3;3) myeloid malignancies as a single disease entity irrespective of blast count.

96 CLL as a disease entity is defined by a relatively parsimonious s

97 lenging to diagnose, and recognition of each disease entity is frequently delayed.

98 clude the disease entity/pathogenic type (if disease entity is not known) followed in order by patter

99 of paradoxical embolism are recognized, the disease entity is still rarely considered and remains un

100 The pathophysiology of this disease entity is unknown although several theories, inv

101 mosome 17 type (FTDP-17), a recently defined disease entity, is clinically characterized by personali

102 While predominant as a disease entity, knowledge voids exist regarding the path

103 mal neutrophilic IgA dermatosis, a rare skin disease entity manifested with blisters and pustules cli

104 Various disease entities may cause dizziness, and the reported f

105 ology and psychiatric symptoms, true natural disease entities may not exist in psychiatry.

106 axia (gluten ataxia) and suggested that this disease entity may account for a large number of patient

107 al wall appear to be highly conserved across disease entities, modulating inflammation in atheroscler

108 mains as to whether this represents a single disease entity, namely mixed connective tissue disease,

109 in immunostaining in the human brain and the disease entity now recognized as PD remains to be determ

110 al processes underlying chronic inflammatory disease entities of different etiology.

111 This review focuses on selected disease entities, operative techniques, perioperative ma

112 on remains whether CLIPPERS is an actual new disease entity or represents a syndrome that includes di

113 ggesting that we are identifying a different disease entity or stage.

114 The primary diagnosis should include the disease entity/pathogenic type (if disease entity is not

115 ositis syndromes comprise multiple, distinct disease entities, perhaps arising from divergent pathoge

116 Nodal MZL seems to be a distinctive disease entity rather than an advanced stage of MALT-typ

117 DLBCL, previously recognized as a single disease entity, represents a heterogeneous group of dise

118 ty with increasingly severe OSA because both disease entities share common inflammatory pathways, act

119 VEGF levels between POEMS patients and other disease entities showing higher serum VEGF in POEMS synd

120 Biliary dyskinesia consists of two disease entities situated at two different anatomical lo

121 Some disease entities such as 'wheat-dependent exercise-induc

122 elet microparticle participation in specific disease entities such as rheumatoid arthritis has been e

123 curves cannot be used in patients with other disease entities, such as hypertrophic cardiomyopathy.

124 terns may be present); score/grade/class for disease entities, such as IgA nephropathy, lupus nephrit

125 evidence to demonstrate that a premalignant disease entity, such as MDS or colonic polyps, can be tr

126 t IDH1(R132MUT) appear to represent distinct disease entities that arise from separate cell types of

127 Depression is a disease entity that causes significant morbidity and mor

128 POSE OF REVIEW: Prostate cancer is a complex disease entity that covers a wide prognosis spectrum.

129 orms of extrapulmonary tuberculosis, it is a disease entity that is very rare in Poland (less than 10

130 by multiple providers, misinformation, and a disease entity that, particularly when active, can adver

131 The most important, recent infectious disease entity to consider is community-acquired methici

132 oach to the diagnosis and treatment of these disease entities using a case presentation format.

133 less, excellent discrimination between these disease entities was achieved by computing hemispheric a

134 er ETO functionally links a broader range of disease entities, we asked whether ETO forms a complex w

135 le that a classification is a list of "real" disease entities, which are defined by a combination of

136 In this article, we first review disease entities, which frequently present with the symp

137 Other cardiovascular disease entities with higher prevalence or unique consid

138 zophrenia and bipolar disorder--are distinct disease entities with specific genetic causes and neuroa

139 nt of the criteria used to identify distinct disease entities with widespread adoption of the 2001 Wo

140 ne mutations (biCEPBA) represents a distinct disease entity with a favorable clinical outcome.

141 ncer in particular is emerging as a specific disease entity with distinct molecular, pathologic, and

142 rovide definitive evidence that PPI-REE is a disease entity with significant molecular overlap with E

143 dicate that driver mutations define distinct disease entities within PMF.

144 ingly, PsA is being recognized as a distinct disease entity worthy of research regarding reliable ass